guaifenesin has been researched along with 2019 Novel Coronavirus Disease in 27 studies
Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Allergic asthma is a chronic respiratory disease caused by an inappropriate immune response." | 5.72 | Gekko gecko extract attenuates airway inflammation and mucus hypersecretion in a murine model of ovalbumin-induced asthma. ( Kim, JS; Lee, JH; Lee, S; Moon, BC; Nam, HH; Noh, P; Ryu, SM; Seo, YS; Yang, S, 2022) |
| "Allergic asthma is a chronic respiratory disease caused by an inappropriate immune response." | 1.72 | Gekko gecko extract attenuates airway inflammation and mucus hypersecretion in a murine model of ovalbumin-induced asthma. ( Kim, JS; Lee, JH; Lee, S; Moon, BC; Nam, HH; Noh, P; Ryu, SM; Seo, YS; Yang, S, 2022) |
| "The pandemic of the coronavirus disease 2019 (COVID-19) has brought a global public health crisis." | 1.62 | The proteomic characteristics of airway mucus from critical ill COVID-19 patients. ( Gu, G; Li, Y; Liu, F; Liu, X; Lu, W; Luo, J; Wang, T; Xu, J; Zhang, Z; Zhao, J; Zhong, N; Zhu, A, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 27 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nam, HH | 1 |
| Lee, JH | 1 |
| Ryu, SM | 1 |
| Lee, S | 1 |
| Yang, S | 1 |
| Noh, P | 1 |
| Moon, BC | 1 |
| Kim, JS | 1 |
| Seo, YS | 1 |
| Kumar, SS | 1 |
| Binu, A | 1 |
| Devan, AR | 1 |
| Nath, LR | 1 |
| Li, D | 1 |
| Luan, N | 1 |
| Li, J | 1 |
| Zhao, H | 1 |
| Zhang, Y | 2 |
| Long, R | 1 |
| Jiang, G | 1 |
| Fan, S | 1 |
| Xu, X | 1 |
| Cao, H | 1 |
| Wang, Y | 1 |
| Liao, Y | 1 |
| Wang, L | 1 |
| Liu, L | 1 |
| Liu, C | 1 |
| Li, Q | 1 |
| Meyerholz, DK | 1 |
| Reznikov, LR | 1 |
| Haroun, RA | 1 |
| Osman, WH | 1 |
| Eessa, AM | 1 |
| Ousingsawat, J | 1 |
| Centeio, R | 1 |
| Cabrita, I | 1 |
| Talbi, K | 1 |
| Zimmer, O | 1 |
| Graf, M | 1 |
| Göpferich, A | 1 |
| Schreiber, R | 1 |
| Kunzelmann, K | 1 |
| Aggarwal, V | 1 |
| Sunder, S | 1 |
| Verma, SR | 1 |
| Pednekar, DD | 1 |
| Liguori, MA | 1 |
| Marques, CNH | 1 |
| Zhang, T | 1 |
| Zhang, N | 1 |
| Zhou, Z | 1 |
| Amoako, K | 1 |
| Gu, H | 1 |
| Dickey, BF | 1 |
| Chen, J | 1 |
| Peebles, RS | 1 |
| Su, P | 1 |
| Zhou, F | 1 |
| Zhang, L | 2 |
| Kodchakorn, K | 1 |
| Chokepaichitkool, T | 1 |
| Kongtawelert, P | 1 |
| Li, H | 1 |
| Kuga, K | 1 |
| Ito, K | 1 |
| Esam, Z | 2 |
| Matson, MJ | 1 |
| Yinda, CK | 1 |
| Seifert, SN | 1 |
| Bushmaker, T | 1 |
| Fischer, RJ | 1 |
| van Doremalen, N | 1 |
| Lloyd-Smith, JO | 1 |
| Munster, VJ | 1 |
| Khashkhosha, HK | 1 |
| Elhadi, M | 1 |
| Pujadas, E | 1 |
| Chaudhry, F | 1 |
| McBride, R | 1 |
| Richter, F | 1 |
| Zhao, S | 1 |
| Wajnberg, A | 1 |
| Nadkarni, G | 1 |
| Glicksberg, BS | 1 |
| Houldsworth, J | 1 |
| Cordon-Cardo, C | 1 |
| Lu, W | 2 |
| Liu, X | 2 |
| Wang, T | 2 |
| Liu, F | 2 |
| Zhu, A | 2 |
| Lin, Y | 1 |
| Luo, J | 2 |
| Ye, F | 1 |
| He, J | 1 |
| Zhao, J | 2 |
| Li, Y | 3 |
| Zhong, N | 2 |
| Poon, WCK | 1 |
| Brown, AT | 1 |
| Direito, SOL | 1 |
| Hodgson, DJM | 1 |
| Le Nagard, L | 1 |
| Lips, A | 1 |
| MacPhee, CE | 1 |
| Marenduzzo, D | 1 |
| Royer, JR | 1 |
| Silva, AF | 1 |
| Thijssen, JHJ | 1 |
| Titmuss, S | 1 |
| Liu, Y | 1 |
| Lv, J | 1 |
| Liu, J | 1 |
| Li, M | 1 |
| Xie, J | 1 |
| Lv, Q | 1 |
| Deng, W | 1 |
| Zhou, N | 1 |
| Zhou, Y | 1 |
| Song, J | 1 |
| Wang, P | 1 |
| Qin, C | 1 |
| Tong, WM | 1 |
| Huang, B | 1 |
| Zhang, Z | 1 |
| Gu, G | 1 |
| Xu, J | 1 |
| Edwards, DA | 1 |
| Ausiello, D | 1 |
| Salzman, J | 1 |
| Devlin, T | 1 |
| Langer, R | 1 |
| Beddingfield, BJ | 1 |
| Fears, AC | 1 |
| Doyle-Meyers, LA | 1 |
| Redmann, RK | 1 |
| Killeen, SZ | 1 |
| Maness, NJ | 1 |
| Roy, CJ | 1 |
| Zhang, H | 1 |
| Zhou, J | 1 |
| Chen, R | 1 |
| Ren, Y | 1 |
| Cai, J | 1 |
| Zhao, L | 1 |
| Fei, X | 1 |
| Liu, Z | 1 |
| Yuan, L | 1 |
| Wang, C | 1 |
| Guo, L | 1 |
| Wang, M | 1 |
| Mao, N | 1 |
| An, C | 1 |
| Xu, L | 1 |
| Long, E | 1 |
| Sloan, A | 1 |
| Cutts, T | 1 |
| Griffin, BD | 1 |
| Kasloff, S | 1 |
| Schiffman, Z | 1 |
| Chan, M | 1 |
| Audet, J | 1 |
| Leung, A | 1 |
| Kobasa, D | 1 |
| Stein, DR | 1 |
| Safronetz, D | 1 |
| Poliquin, G | 1 |
| Posch, W | 1 |
| Lass-Flörl, C | 1 |
| Wilflingseder, D | 1 |
| Wittig, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Nasopharyngeal Wash With Normal Saline on SARS-CoV2 Viral Load: A Randomized Controlled Trial[NCT05525832] | 50 participants (Actual) | Interventional | 2021-06-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for guaifenesin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Influence of SARS-CoV-2 on airway mucus production: A review and proposed model.
Topics: Animals; COVID-19; Ferrets; Mucus; Pandemics; SARS-CoV-2 | 2022 |
Disease-associated dysbiosis and potential therapeutic role of Akkermansia muciniphila, a mucus degrading bacteria of gut microbiome.
Topics: COVID-19; Diabetes Mellitus, Type 2; Dysbiosis; Gastrointestinal Microbiome; Humans; Mucins; Mucus; | 2022 |
From Static to Dynamic: A Review on the Role of Mucus Heterogeneity in Particle and Microbial Transport.
Topics: COVID-19; Drug Delivery Systems; Humans; Mucus; SARS-CoV-2 | 2022 |
A hypothesis on the role of the human immune system in covid-19.
Topics: Ageusia; Angiotensin-Converting Enzyme 2; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-1 | 2020 |
Transmission risk of viruses in large mucosalivary droplets on the surface of objects: A time-based analysis.
Topics: Air Microbiology; Bacteria; Cough; COVID-19; Desiccation; Disease Transmission, Infectious; Equipmen | 2021 |
[Mucociliary clearance in COVID-19 - an underestimated danger area in early phase of disease?]
Topics: Animals; Cough; COVID-19; Humans; Mucociliary Clearance; Mucus; SARS-CoV-2 | 2021 |
21 other studies available for guaifenesin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Gekko gecko extract attenuates airway inflammation and mucus hypersecretion in a murine model of ovalbumin-induced asthma.
Topics: Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; COVID-19; Cytokines; Female; F | 2022 |
Mucus targeting as a plausible approach to improve lung function in COVID-19 patients.
Topics: Asthma; COVID-19; Humans; Lung; Mucus; SARS-CoV-2 | 2021 |
Waning antibodies from inactivated SARS-CoV-2 vaccination offer protection against infection without antibody-enhanced immunopathology in rhesus macaque pneumonia models.
Topics: Alveolar Epithelial Cells; Animals; Antibodies, Neutralizing; Antibodies, Viral; Antibody-Dependent | 2021 |
Evaluation of serum total sialic acid in moderate COVID-19 patients with and without gastrointestinal tract manifestations.
Topics: Adult; Biomarkers; COVID-19; Enzyme-Linked Immunosorbent Assay; Female; Gastrointestinal Tract; Huma | 2022 |
Airway Delivery of Hydrogel-Encapsulated Niclosamide for the Treatment of Inflammatory Airway Disease.
Topics: Animals; Asthma; Cells, Cultured; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal; Drug Ca | 2022 |
Airway Mucus Dysfunction in COVID-19.
Topics: COVID-19; Humans; Mucus; Prevalence; Respiratory System | 2022 |
Motile cilia and microvillar: accomplices of SARS-CoV-2 in penetrating mucus barrier and infecting airway epithelium.
Topics: Cilia; COVID-19; Epithelium; Humans; Mucus; SARS-CoV-2 | 2023 |
Purification and characterisation of heparin-like sulfated polysaccharides with potent anti-SARS-CoV-2 activity from snail mucus of Achatina fulica.
Topics: Animals; COVID-19; Glycosaminoglycans; Heparin; Humans; Mucus; Polysaccharides; SARS-CoV-2; Snails; | 2023 |
Visual prediction and parameter optimization of viral dynamics in the mucus milieu of the upper airway based on CFPD-HCD analysis.
Topics: COVID-19; Humans; Mucus; Nasal Cavity; Nasopharynx; SARS-CoV-2 | 2023 |
Protective potential of expectorants against COVID-19.
Topics: Air Microbiology; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug T | 2020 |
Effect of Environmental Conditions on SARS-CoV-2 Stability in Human Nasal Mucus and Sputum.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Hot Temperature; Humans; Humidity; Mucus; Nasal C | 2020 |
SARS-CoV-2 viral load predicts COVID-19 mortality.
Topics: Aged; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Male; Middle Aged; Mucus; N | 2020 |
Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 patients.
Topics: Cohort Studies; COVID-19; Critical Illness; Female; Humans; Male; Middle Aged; Mucin 5AC; Mucin-1; M | 2021 |
Soft matter science and the COVID-19 pandemic.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Disinfection; Humans; Mucus; Nanoparticles; Pande | 2020 |
Protective potential of expectorants against COVID-19.
Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dioxolanes | 2020 |
Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19.
Topics: Animals; Cell Line; COVID-19; Epithelial Cells; Humans; Hypoxia; Interferon-beta; Interferon-gamma; | 2020 |
The proteomic characteristics of airway mucus from critical ill COVID-19 patients.
Topics: Aged; Amino Acids; Bronchoscopy; Case-Control Studies; Cholesterol; COVID-19; Critical Illness; Fema | 2021 |
Exhaled aerosol increases with COVID-19 infection, age, and obesity.
Topics: Aerosols; Age Factors; Animals; Body Mass Index; Cohort Studies; COVID-19; Exhalation; Humans; Mucus | 2021 |
Autopsy and Histologic Findings of Patients with New Coronavirus Pneumonia: The Pathologic Associations with Hypoxemia.
Topics: Aged; Aged, 80 and over; Alveolar Epithelial Cells; Autopsy; Cell Aggregation; COVID-19; Female; Hum | 2021 |
Simulated sunlight decreases the viability of SARS-CoV-2 in mucus.
Topics: COVID-19; Decontamination; Humans; Microbial Viability; Mucus; SARS-CoV-2; Sunlight; Virus Inactivat | 2021 |
SARS-CoV-2-infected primary human airway epithelia illustrate mucus hypersecretion.
Topics: COVID-19; Humans; Mucus; Respiratory System; SARS-CoV-2 | 2021 |